NEW
Font size
S
M
L
XL
WorksheetsPsychobiology and Psychopharmacology
Total questions: 22
Worksheet time: 6hrs 30mins
Name
Class
Date
1.
What causes Thought Disorders?
a)
elevated dopamine levels in basal ganglia and decreased serotonin receptor
b)
decreased serotonin levels and norepinephrine in the brain
c)
interactions between norepinephrine, dopamine, serotonin, acetylcholine, GABA acid, and peptides
d)
elevated levels of serotonin, norepinephrine, decreased levels of GABA contribute to dysfunctions
2.
What causes Depression?
a)
elevated dopamine levels in basal ganglia and decreased serotonin receptor
b)
decreased serotonin levels and norepinephrine in the brain
c)
interactions between norepinephrine, dopamine, serotonin, acetylcholine, GABA acid, and peptides
d)
elevated levels of serotonin, norepinephrine, decreased levels of GABA contribute to dysfunctions
3.
What causes Bipolar Disorder?
a)
elevated dopamine levels in basal ganglia and decreased serotonin receptor
b)
decreased serotonin levels and norepinephrine in the brain
c)
interactions between norepinephrine, dopamine, serotonin, acetylcholine, GABA acid, and peptides
d)
elevated levels of serotonin, norepinephrine, decreased levels of GABA contribute to dysfunctions
4.
What causes Anxiety Disorders?
a)
elevated dopamine levels in basal ganglia and decreased serotonin receptor
b)
decreased serotonin levels and norepinephrine in the brain
c)
interactions between norepinephrine, dopamine, serotonin, acetylcholine, GABA acid, and peptides
d)
elevated levels of serotonin, norepinephrine, decreased levels of GABA contribute to dysfunctions
5.
Thought Disorders are due to
__________ __________ levels in basal ganglia.
__________ __________ levels in basal ganglia.
a)
increased dopamine and decreased serotonin
b)
increased serotonin and decreased dopamine
c)
increased norepinephrine
d)
decreased acetylcholine
6.
Decreased serotonin receptor activity may also contribute to the development of _________.
a)
Thought Disorders
b)
Anxiety
c)
Bipolar Disorder
d)
Depression
7.
What is the most involved circuit for Depression?
a)
locus coeruleus
b)
raphe nucleus
8.
What is the most involved circuit for Anxiety?
a)
locus coeruleus
b)
raphe nucleus
9.
Which of the below is NOT an involved area of the brain for Mood Disorders?
a)
brainstem, spinal cord, and cerebellum
b)
prefrontal cortex and amygdala
c)
hippocampus
d)
basal ganglia
10.
Bipolar may be due to interactions between norepinephrine, dopamine, serotonin, acetylcholine, GABA acid, and endorphins.
Which of the listed neurotransmitters does not pertain to Bipolar?
Which of the listed neurotransmitters does not pertain to Bipolar?
a)
Endorphins
b)
Serotonin
c)
Dopamine
d)
GABA
11.
_________ levels of serotonin and norepinephrine and _________ levels of GABA contribute to dysfunctions of Anxiety.
a)
Elevated; Decreased
b)
Decreased; Elevated
12.
TRUE or FALSE: Dysregulation involves dopamine, norepinephrine, and other neurotransmitters.
a)
TRUE
b)
FALSE
13.
What is Neuroleptic Malignant Syndrome?
a)
Life threatening complication of medication abuse
b)
Life threatening complication of antipsychotic medication
c)
Life threatening complication of alcohol
d)
Life threatening complication of antidepressant medication
14.
When does Neuroleptic Malignant Syndrome usually develop?
a)
within the first week of antipsychotic medication (90%)
b)
within the first 2 weeks of antipsychotic medication (90%)
c)
within the first week of antidepressant medication (90%)
d)
within the first 2 weeks of antidepressant medication (90%)
15.
Neuroleptic Malignant Syndrome may also present within ______ following exposure to dopamine agonist.
a)
12 hours
b)
24 hours
c)
48 hours
d)
72 hours
16.
Neuroleptic Malignant Syndrome may also present within 72 hours following exposure to ________ agonist.
a)
dopamine
b)
serotonin
c)
adrenaline
d)
endorphins
17.
What is the classification of Neuroleptic Malignant Syndrome?
a)
Movement Disorder
b)
Cognitive Disorder
c)
Mood Disorder
d)
Thought Disorder
18.
Which of the below is NOT a symptom of Metabolic Syndrome?
a)
Abdominal Obesity
b)
DECREASED Triglycerides
c)
HDL cholesterol
d)
Blood Pressure and Fasting Blood Sugar
19.
What is considered Abdominal Obesity for white men and white women?
a)
white men: 37+
white women: 31.5+
white women: 31.5+
b)
white men: 31.5+
white women: 37+
white women: 37+
c)
white men: 35.5+
white women: 31.5+
white women: 31.5+
d)
white men: 38.5+
white women: 35.5+
white women: 35.5+
20.
What is considered Abdominal Obesity for South Americans and South Asian men and women?
a)
men: 37+
women: 32.5+
women: 32.5+
b)
men: 31.5+
women: 37+
women: 37+
c)
men: 35.5+
women: 31.5+
women: 31.5+
d)
men: 38.5+
women: 35.5+
women: 35.5+
21.
Which of the below is NOT a treatment For Neuroleptic Malignant Syndrome?
a)
discontinue neuroleptics
b)
blood pressure and R/O2
c)
warming blankets
d)
medication: Dantrolene or Bromocriptine to relieve rigidity
22.
Which of the below medications is NOT used to relieve rigidity?
a)
Dantrolene
b)
Lithium
c)
Bromocriptine
Reset
